Heart Transplantation Ameliorates Ambulation Capacity in Patients With Muscular Dystrophy - An Analysis of 9 Cases.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 02 2019
Historique:
pubmed: 29 1 2019
medline: 31 3 2020
entrez: 29 1 2019
Statut: ppublish

Résumé

Heart transplantation (HTx) is reported to have a comparable effect on the prognosis of heart failure patients without muscular disease and for those with muscular dystrophy (MD). However, little is known about the changes in muscular diseases in patients with MD after HTx. Methods and Results: We assessed the ambulatory capacity of 9 patients with MD who underwent HTx. All patients demonstrated improvement in ambulation to varying degrees and 1 patient successfully climbed Mount Fuji 3.8 years after HTx. HTx potentially improves not only the prognosis but also the ambulatory capacity of patients with MD.

Sections du résumé

BACKGROUND
Heart transplantation (HTx) is reported to have a comparable effect on the prognosis of heart failure patients without muscular disease and for those with muscular dystrophy (MD). However, little is known about the changes in muscular diseases in patients with MD after HTx. Methods and Results: We assessed the ambulatory capacity of 9 patients with MD who underwent HTx. All patients demonstrated improvement in ambulation to varying degrees and 1 patient successfully climbed Mount Fuji 3.8 years after HTx.
CONCLUSIONS
HTx potentially improves not only the prognosis but also the ambulatory capacity of patients with MD.

Identifiants

pubmed: 30686808
doi: 10.1253/circj.CJ-18-1060
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

684-686

Auteurs

Osamu Seguchi (O)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Kensuke Kuroda (K)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Tomoyuki Fujita (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center.

Yuto Kumai (Y)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Seiko Nakajima (S)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Takuya Watanabe (T)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Masanobu Yanase (M)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Yorihiko Matsumoto (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center.

Satsuki Fukushima (S)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center.

Koichi Kimura (K)

Department of Advanced Medical Science, The Institute of Medical Science, The University of Tokyo.

Norihide Fukushima (N)

Department of Transplant Medicine, National Cerebral and Cardiovascular Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH